Internal Medicine, Hematology & Oncology · Charlotte, NC
NPI
1053365320
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
3
Medicare group memberships
Hospitals
5
Hospital affiliations
2711 Randolph Rd Ste 400
Charlotte, NC, 28207
Phone (707) 342-9577
Groups this clinician bills Medicare through
Medicare paid, 2024
$4.8M
226,543 services
Medicare patients, 2024
905
Average age 76
Drug cost, 2024
$5.8M
1,648 prescriptions
Company payments, 2025
$5,825
From 39 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Justin P Favaro was code J0881 (injection, darbepoetin alfa, 1 microgram (non-esrd use)), 45,900 times for 18 patients. In total Justin P Favaro billed 226,543 services in 173 codes, and Medicare paid $4.8M.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-01-27.
| Code |
|---|
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use) | Office | 45,900 | 18 | $2.33 | $107K |
| J0897 Injection, denosumab, 1 mg | Office | 23,880 | 131 | $20.55 | $491K |
| J1569 Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg | Office | 10,718 | 26 | $35.59 | $381K |
| J1453 Injection, fosaprepitant, 1 mg | Office | 6,450 | 15 | $0.11 | $697 |
| J1437 Injection, ferric derisomaltose, 10 mg | Office | 5,900 | 54 | $15.74 | $93K |
| J1449 Injection, eflapegrastim-xnst, 0.1 mg | Office | 4,752 | 17 | $20.53 | $98K |
| J3111 Injection, romosozumab-aqqg, 1 mg | Office | 3,570 | 11 | $8.59 | $31K |
| 85025 Blood Count | Office | 3,024 | 572 | $7.60 | $23K |
| 36415 Venipuncture Blood Collection | Office | 2,680 | 576 | $8.65 | $23K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 2,221 | 52 | $0.09 | $201 |
| Q5123 Injection, rituximab-arrx, biosimilar, (riabni), 10 mg | Office | 2,190 | 14 | $31.28 | $68K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 1,987 | 225 | $49.81 | $99K |
| 99214 Office E&M - Established | Office | 1,607 | 545 | $96.89 | $156K |
| 99215 Office E&M - Established | Office | 856 | 190 | $141.68 | $121K |
| 96372 Injection Administration | Office | 756 | 206 | $11.15 | $8,432 |
By year: 2022 $3.9M for 206,132 services; 2023 $3.5M for 177,673 services; 2024 $4.8M for 226,543 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 3,024 | 572 | $7.60 | $23K |
| 36415 Venipuncture Blood Collection | 2,680 | 576 | $8.65 | $23K |
| 81002 Clinical Chemistry | 123 | 48 | $3.41 | $419 |
Medicare prescription drug claims, 2024
In 2024, the drug Justin P Favaro prescribed most often to Medicare patients was Acyclovir, with 73 prescriptions and refills. In total Justin P Favaro wrote 1,648 Medicare prescriptions that cost $5.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Acyclovir Generic | 73 | 106 | 20 | $684 |
| Pantoprazole Sodium Generic | 57 | 145 | 28 | $552 |
| Lenalidomide Generic | 57 | 57 | Under 11 | $736K |
| Prednisone Generic | 53 | 74 | 25 | $434 |
| Eliquis Apixaban | 48 | 60 | 15 | $34K |
| Ciprofloxacin Hcl Generic | 48 | 51 | 34 | $397 |
| Brukinsa Zanubrutinib | 41 | 41 | Under 11 | $536K |
| Dexamethasone Generic | 41 | 56 | 25 | $934 |
| Allopurinol Generic | 39 | 86 | 19 | $278 |
| Potassium Chloride Generic | 37 | 51 | 17 | $407 |
| Anastrozole Generic | 37 | 79 | 12 | $477 |
| Levothyroxine Sodium Generic | 34 | 62 | 15 | $301 |
| Xarelto Rivaroxaban | 32 | 46 | 11 | $26K |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 29 | 29 | 27 | $246 |
| Orgovyx Relugolix | 28 | 28 | Under 11 | $72K |
Brand drugs: - claims; generic drugs: 1,121 claims; opioid claims: 58.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Justin P Favaro $5,825 ($5,825 in general payments such as food, travel and fees) from 39 companies. The largest payer was BeOne Medicines USA, Inc. with $3,013.
| Company | Payments | Amount |
|---|---|---|
| BeOne Medicines USA, Inc. ONC | 5 | $3,013 |
| Pfizer Inc. PFE | 16 | $426 |
| E.R. Squibb & Sons, L.L.C. BMY | 14 | $304 |
| Janssen Biotech, Inc. JNJ | 5 | $296 |
| Novartis Pharmaceuticals Corporation NVS | 10 | $243 |
| BeiGene USA, Inc. ONC | 1 | $165 |
| Adaptive Biotechnologies Corporation ADPT | 5 | $118 |
| Array Biopharma Inc PFE | 5 | $104 |
| Jazz Pharmaceuticals Inc. JAZZ | 3 | $98.77 |
| Abbvie Inc. ABBV | 5 | $97.59 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.